Michael J. Puzo’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $275K | Hold |
1,976
| – | – | 0.08% | 62 |
|
|
2025
Q4 | $243K | Hold |
1,976
| – | – | 0.07% | 67 |
|
|
2025
Q3 | $219K | Sell |
1,976
-124
| -6% | -$14.1K | 0.06% | 69 |
|
|
2025
Q2 | $233K | Hold |
2,100
| – | – | 0.07% | 68 |
|
|
2025
Q1 | $235K | Buy |
+2,100
| New | +$217K | 0.07% | 68 |
|
|
2024
Q1 | – | Sell |
-2,600
| Closed | -$211K | – | 77 |
|
|
2023
Q4 | $211K | Buy |
+2,600
| New | +$202K | 0.07% | 73 |
|
|
2023
Q3 | – | Sell |
-2,600
| Closed | -$200K | – | 77 |
|
|
2023
Q2 | $200K | Sell |
2,600
-50
| -2% | -$3.99K | 0.06% | 78 |
|
|
2023
Q1 | $220K | Sell |
2,650
-50
| -2% | -$4.14K | 0.07% | 74 |
|
|
2022
Q4 | $232K | Buy |
+2,700
| New | +$214K | 0.08% | 72 |
|
|
2022
Q1 | – | Sell |
-3,000
| Closed | -$218K | – | 81 |
|
|
2021
Q4 | $218K | Hold |
3,000
| – | – | 0.06% | 81 |
|
|
2021
Q3 | $210K | Hold |
3,000
| – | – | 0.07% | 75 |
|
|
2021
Q2 | $207K | Sell |
3,000
-1,400
| -32% | -$93.5K | 0.06% | 76 |
|
|
2021
Q1 | $284K | Hold |
4,400
| – | – | 0.09% | 69 |
|
|
2020
Q4 | $256K | Sell |
4,400
-100
| -2% | -$6.03K | 0.08% | 72 |
|
|
2020
Q3 | $284K | Sell |
4,500
-100
| -2% | -$6.93K | 0.1% | 68 |
|
|
2020
Q2 | $354K | Hold |
4,600
| – | – | 0.13% | 64 |
|
|
2020
Q1 | $344K | Sell |
4,600
-100
| -2% | -$6.91K | 0.15% | 62 |
|
|
2019
Q4 | $305K | Sell |
4,700
-845
| -15% | -$55K | 0.11% | 69 |
|
|
2019
Q3 | $352K | Hold |
5,545
| – | – | 0.13% | 66 |
|
|
2019
Q2 | $375K | Sell |
5,545
-400
| -7% | -$26.3K | 0.14% | 66 |
|
|
2019
Q1 | $387K | Sell |
5,945
-50
| -0.8% | -$3.32K | 0.15% | 61 |
|
|
2018
Q4 | $375K | Sell |
5,995
-9,404
| -61% | -$657K | 0.17% | 61 |
|
|
2018
Q3 | $1.19M | Sell |
15,399
-5,599
| -27% | -$423K | 0.45% | 44 |
|
|
2018
Q2 | $1.49M | Buy |
20,998
+3,202
| +18% | +$226K | 0.63% | 38 |
|
|
2018
Q1 | $1.34M | Sell |
17,796
-100
| -0.6% | -$7.95K | 0.57% | 40 |
|
|
2017
Q4 | $1.28M | Buy |
17,896
+2,050
| +13% | +$156K | 0.53% | 42 |
|
|
2017
Q3 | $1.28M | Sell |
15,846
-685
| -4% | -$52.4K | 0.67% | 40 |
|
|
2017
Q2 | $1.17M | Sell |
16,531
-790
| -5% | -$52.6K | 0.63% | 40 |
|
|
2017
Q1 | $1.18M | Buy |
17,321
+2,555
| +17% | +$180K | 0.65% | 41 |
|
|
2016
Q4 | $1.06M | Sell |
14,766
-7,155
| -33% | -$532K | 0.61% | 43 |
|
|
2016
Q3 | $1.74M | Buy |
21,921
+3,967
| +22% | +$322K | 1% | 36 |
|
|
2016
Q2 | $1.5M | Buy |
17,954
+3,563
| +25% | +$316K | 0.99% | 37 |
|
|
2016
Q1 | $1.32M | Buy |
14,391
+5,886
| +69% | +$531K | 0.88% | 39 |
|
|
2015
Q4 | $861K | Sell |
8,505
-16
| -0.2% | -$1.67K | 0.6% | 44 |
|
|
2015
Q3 | $837K | Sell |
8,521
-244
| -3% | -$27.1K | 0.59% | 47 |
|
|
2015
Q2 | $1.03M | Buy |
8,765
+85
| +1% | +$9.29K | 0.66% | 40 |
|
|
2015
Q1 | $852K | Sell |
8,680
-187
| -2% | -$19K | 0.54% | 52 |
|
|
2014
Q4 | $836K | Sell |
8,867
-420
| -5% | -$43.4K | 0.55% | 51 |
|
|
2014
Q3 | $989K | Sell |
9,287
-190
| -2% | -$18.6K | 0.68% | 44 |
|
|
2014
Q2 | $786K | Sell |
9,477
-2,423
| -20% | -$189K | 0.55% | 48 |
|
|
2014
Q1 | $843K | Sell |
11,900
-250
| -2% | -$19.6K | 0.61% | 48 |
|
|
2013
Q4 | $912K | Sell |
12,150
-500
| -4% | -$34.8K | 0.67% | 42 |
|
|
2013
Q3 | $795K | Sell |
12,650
-250
| -2% | -$14.9K | 0.66% | 42 |
|
|
2013
Q2 | $661K | Buy |
+12,900
| New | +$672K | 0.58% | 46 |
|
Other funds holding GILD
VCM
VPM
Michael J. Puzo's GILD Position: Q1 2026 in Review
Michael J. Puzo held its Gilead Sciences (GILD) position steady in Q1 2026 at 1,976 shares worth $275K. The position accounts for 0.08% of the portfolio, ranked #62.
Michael J. Puzo first reported a position in GILD in Q2 2013 and has held it in 44 quarters since. The position peaked at $1.74M in Q3 2016. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Michael J. Puzo held 1,976 shares of Gilead Sciences worth $275K as of Q1 2026.
- Michael J. Puzo left its Gilead Sciences share count unchanged in Q1 2026.
- Gilead Sciences made up 0.08% of Michael J. Puzo's portfolio in Q1 2026, its #62 holding.
- Michael J. Puzo first reported a position in Gilead Sciences in Q2 2013 and has held it in 44 quarters since.
- Michael J. Puzo's Gilead Sciences position peaked at $1.74M in Q3 2016.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Michael J. Puzo's 13F filing for Q1 2026, filed 7 May 2026.